Advertisement

Welcome to the new AJNR, Updated Hall of Fame, and more. Read the full announcements.

AJNR is seeking candidates for the position of Associate Section Editor, AJNR Case Collection. Read the full announcement.

 

Index by author

November 01, 2016; Volume 37,Issue 11

  1. Gobin, Y.P.

    1. INTERVENTIONAL
      Geographic Differences in Endovascular Treatment and Retreatment of Cerebral Aneurysms
      A.S. Turk, S.C. Johnston, S. Hetts, J. Mocco, J. English, Y. Murayama, C.J. Prestigiacomo, D. Lopes, Y.P. Gobin, K. Carroll and C. McDougall
      American Journal of Neuroradiology November 2016, 37 (11) 2055-2059; DOI: https://doi.org/10.3174/ajnr.A4857

  2. Goff, R.D.

    1. HEAD & NECK
      Is Hypoglossal Nerve Palsy Caused by Craniocervical Junction Degenerative Disease an Underrecognized Entity?
      S.M. Weindling, R.D. Goff, C.P. Wood, D.R. DeLone and J.M. Hoxworth
      American Journal of Neuroradiology November 2016, 37 (11) 2138-2143; DOI: https://doi.org/10.3174/ajnr.A4885

  3. Gogia, B.

    1. FELLOWS' JOURNAL CLUBHEAD & NECK
      Imaging Features of Malignant Lacrimal Sac and Nasolacrimal Duct Tumors
      V.A. Kumar, B. Esmaeli, S. Ahmed, B. Gogia, J.M. Debnam and L.E. Ginsberg
      American Journal of Neuroradiology November 2016, 37 (11) 2134-2137; DOI: https://doi.org/10.3174/ajnr.A4882

      This case series presents 18 patients with primary and secondary malignant lacrimal sac and nasolacrimal duct tumors and their pattern of tumor spread. Squamous cell carcinoma was the most common histology and, in 15/18 patients tumor involved both the lacrimal sac and duct at the time of diagnosis. In 11/16 patients on CT, the nasolacrimal bony canal was smoothly expanded without erosive changes. Tumor was not observed solely within the nasolacrimal duct in any patient. Only 1 patient presented with nodal metastasis and there was no intracranial tumor extension or perineural tumor spread. The authors conclude that malignant lacrimal sac and nasolacrimal duct tumors tend to expand the nasolacrimal bony canal, rather than erode it. CT was superior to MR imaging in characterizing expansion versus erosion of the nasolacrimal bony canal.

  4. Grinband, J.

    1. ADULT BRAIN
      Open Access
      A Simple Automated Method for Detecting Recurrence in High-Grade Glioma
      T.K. Yanagihara, J. Grinband, J. Rowley, K.A. Cauley, A. Lee, M. Garrett, M. Afghan, A. Chu and T.J.C. Wang
      American Journal of Neuroradiology November 2016, 37 (11) 2019-2025; DOI: https://doi.org/10.3174/ajnr.A4873

  5. Gu, H.

    1. FUNCTIONAL
      Open Access
      Disrupted Brain Connectivity Patterns in Patients with Type 2 Diabetes
      Y. Cui, S.-F. Li, H. Gu, Y.-Z. Hu, X. Liang, C.-Q. Lu, Y. Cai, C.-X. Wang, Y. Yang and G.-J. Teng
      American Journal of Neuroradiology November 2016, 37 (11) 2115-2122; DOI: https://doi.org/10.3174/ajnr.A4858

  6. Guez, D.

    1. EDITOR'S CHOICEADULT BRAIN
      Early Biomarkers from Conventional and Delayed-Contrast MRI to Predict the Response to Bevacizumab in Recurrent High-Grade Gliomas
      D. Daniels, D. Guez, D. Last, C. Hoffmann, D. Nass, A. Talianski, G. Tsarfaty, S. Salomon, A.A. Kanner, D.T. Blumenthal, F. Bokstein, S. Harnof, D. Yekutieli, S. Zamir, Z.R. Cohen, L. Zach and Y. Mardor
      American Journal of Neuroradiology November 2016, 37 (11) 2003-2009; DOI: https://doi.org/10.3174/ajnr.A4866

      Twenty-four patients with recurrent high-grade gliomas were scanned before and during bevacizumab treatment with standard and delayed-contrast MRI. The mean change in lesion volumes of responders (overall survival, >1 year) and nonresponders (overall survival, <1 year) was evaluated. Treatment-response-assessment maps (TRAMs) were calculated by subtracting conventional T1WI (acquired a few minutes postcontrast) from delayed T1WI (acquired with a delay of >1 hour postcontrast). These maps depict the spatial distribution of contrast accumulation and clearance. At progression, the increase in lesion volumes in delayed-contrast MR imaging was 37.5% higher than the increase in conventional T1WI. The authors conclude that the benefit of standard and delayed-contrast MRI for assessing and predicting the response to bevacizumab was demonstrated and that the increased sensitivity of delayed-contrast MRI reflects its potential contribution to the management of bevacizumab-treated patients with recurrent HGG.

  7. Gunderson, T.

    1. INTERVENTIONAL
      Open Access
      Wall Apposition Is a Key Factor for Aneurysm Occlusion after Flow Diversion: A Histologic Evaluation in 41 Rabbits
      A. Rouchaud, C. Ramana, W. Brinjikji, Y.-H. Ding, D. Dai, T. Gunderson, J. Cebral, D.F. Kallmes and R. Kadirvel
      American Journal of Neuroradiology November 2016, 37 (11) 2087-2091; DOI: https://doi.org/10.3174/ajnr.A4848

  8. Gupta, V.

    1. Embryologic Anatomic Variations: Challenges in Intra-Arterial Chemotherapy for Intraocular Retinoblastoma
      C. Paruthi, V. Gupta and N. Khandelwal
      American Journal of Neuroradiology November 2016, 37 (11) E71-E72; DOI: https://doi.org/10.3174/ajnr.A4905
« Previous (Pages : 1 2 ... 2)next »
Back to top

In this issue

Advertisement
Advertisement